The Greenberg Traurig China Newsletter provides an overview of key developments in Chinese legislation. This issue features the following articles:

  1. CFDA Provides Clarity on Administration of Imported Drug Registration
  2. CIRC to Standardize Internal Control System for Use of Insurance Funds
  3. SZSE Strengthens Information Disclosure for Joint Investment Made by Listed Companies and Specialized Investment Institutions
  4. CFDA Sought Public Opinions on the Draft Amendments to the Drug Administration Law and the Regulations for Supervision and Administration of Medical Devices 
  5. First-Time Amendments to Anti-Unfair Competition Law Issued
  6. NDRC Issues Administrative Measures for Outbound Investment of Enterprises
  7. MOF and SAT Improve Tax Credit Policy for Enterprises’ Foreign-Sourced Income
  8. Profits Distributed to Overseas Investors Exempt from Withholding Tax if Used for Direct Investment
The Greenberg Traurig China Newsletter provides an overview of key developments in Chinese legislation. This issue features the following articles: